fashion -WSS

fashion

author：fashion 2025-08-28 10:52:07 - browse：465

Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals. -- biotech coverage from STAT — Scientists Christina Frey and Paul Negulescu work in a lab at Vertex Pharmaceuticals in San Diego. Sandy Huffaker for STAT

A pain relief drug developed by Vertex Pharmaceuticals succeeded in late-stage clinical trials, the company announced Tuesday, bringing the biopharma giant a step closer to launching what observers believe could be a potential blockbuster and upending decades of pharma failure in a complicated field.

In a pair of randomized, placebo-controlled Phase 3 trials for patients with pain after a tummy tuck or bunion surgery, the drug showed statistically significant pain reduction compared to placebo, meeting the primary endpoints for these studies and the expectations of market analysts. But the experimental therapy didn’t relieve pain better than a combination of acetaminophen and the opioid hydrocodone, a key secondary endpoint observers had been waiting on. And in the bunionectomy trial, the opioid comparator outperformed VX-548 at soothing pain.

The drug, a small molecule known as VX-548, blocks pain-sensing neurons from signaling the pain without the addictive potential of opioids. It was generally safe, with fewer patients on VX-548 reporting adverse events than those taking the placebo.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

focus

WSS

Victims of gun violence feel impacts long after bullet wound

Sanofi CEO defends move to abandon profit guidance, boost research

Medicare will require more price transparency from hospitals

Medicare solvency divides Republicans at the presidential debate

Change Healthcare payments predicted restored March 15

Biotech incubator Curie.Bio graduates its first startup

Wikipedia

fashion

leisure time

At least 13 dead in Texas as scorching temps continue

Excited delirium, Elijah McClain, and emergency physicians

Hepatitis C has a cure — but many Americans still lack access to it

Amylyx ALS drug failure raises questions and concerns

Duchenne breakthrough therapy leaves behind pioneering families

A deep dive into Applied Therapeutics’ data, and questions on Cassava

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In his State of the Union, Biden takes clear aim at 'Big Pharma'

New air purifier tech could be key to improving indoor air quality

Headspace, Meta partner to launch VR meditation app for Quest

hotspot

Change Healthcare cyberattack prompts Medicare loan program

UnitedHealth quietly bought dozens of outpatient centers

Amylyx ALS drug failure raises questions and concerns

CDC marks new Covid

Sen. Paul opposes bill to ban Chinese biotechs

A clever new way to fix Medicaid and graduate medical education

focus

focus

knowledge

hotspot